• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (903)  • Contact me when this article is cited  Related Content  • Related letter  • Related articles  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Macular Degeneration  • Randomized Controlled Trial  • Articles for Residents  • Alert me on articles by topic  Social Bookmarking   What's this?

AREDS Report No. 8

Age-Related Eye Disease Study Research Group

Arch Ophthalmol. 2001;119:1417-1436.

Background  Observational and experimental data suggest that antioxidant and/or zinc supplements may delay progression of age-related macular degeneration (AMD) and vision loss.

Objective  To evaluate the effect of high-dose vitamins C and E, beta carotene, and zinc supplements on AMD progression and visual acuity.

Design  The Age-Related Eye Disease Study, an 11-center double-masked clinical trial, enrolled participants in an AMD trial if they had extensive small drusen, intermediate drusen, large drusen, noncentral geographic atrophy, or pigment abnormalities in 1 or both eyes, or advanced AMD or vision loss due to AMD in 1 eye. At least 1 eye had best-corrected visual acuity of 20/32 or better. Participants were randomly assigned to receive daily oral tablets containing: (1) antioxidants (vitamin C, 500 mg; vitamin E, 400 IU; and beta carotene, 15 mg); (2) zinc, 80 mg, as zinc oxide and copper, 2 mg, as cupric oxide; (3) antioxidants plus zinc; or (4) placebo.

Main Outcome Measures  (1) Photographic assessment of progression to or treatment for advanced AMD and (2) at least moderate visual acuity loss from baseline (15 letters). Primary analyses used repeated-measures logistic regression with a significance level of .01, unadjusted for covariates. Serum level measurements, medical histories, and mortality rates were used for safety monitoring.

Results  Average follow-up of the 3640 enrolled study participants, aged 55-80 years, was 6.3 years, with 2.4% lost to follow-up. Comparison with placebo demonstrated a statistically significant odds reduction for the development of advanced AMD with antioxidants plus zinc (odds ratio [OR], 0.72; 99% confidence interval [CI], 0.52-0.98). The ORs for zinc alone and antioxidants alone are 0.75 (99% CI, 0.55-1.03) and 0.80 (99% CI, 0.59-1.09), respectively. Participants with extensive small drusen, nonextensive intermediate size drusen, or pigment abnormalities had only a 1.3% 5-year probability of progression to advanced AMD. Odds reduction estimates increased when these 1063 participants were excluded (antioxidants plus zinc: OR, 0.66; 99% CI, 0.47-0.91; zinc: OR, 0.71; 99% CI, 0.52-0.99; antioxidants: OR, 0.76; 99% CI, 0.55-1.05). Both zinc and antioxidants plus zinc significantly reduced the odds of developing advanced AMD in this higher-risk group. The only statistically significant reduction in rates of at least moderate visual acuity loss occurred in persons assigned to receive antioxidants plus zinc (OR, 0.73; 99% CI, 0.54-0.99). No statistically significant serious adverse effect was associated with any of the formulations.

Conclusions  Persons older than 55 years should have dilated eye examinations to determine their risk of developing advanced AMD. Those with extensive intermediate size drusen, at least 1 large druse, noncentral geographic atrophy in 1 or both eyes, or advanced AMD or vision loss due to AMD in 1 eye, and without contraindications such as smoking, should consider taking a supplement of antioxidants plus zinc such as that used in this study.

The AREDS investigators have no commercial or proprietary interest in the supplements used in this study.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Participants and Methods in AREDS Report No. 8
W. Rex Hawkins
Arch Ophthalmol. 2008;126(1):146-147.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Antioxidants and Zinc to Prevent Progression of Age-Related Macular Degeneration
Lee M. Jampol and Frederick L. Ferris, III
JAMA. 2001;286(19):2466-2468.
EXTRACT | FULL TEXT  

A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss: AREDS Report No. 9
Age-Related Eye Disease Study Research Group
Arch Ophthalmol. 2001;119(10):1439-1452.
ABSTRACT | FULL TEXT  

Antioxidants, Zinc, and Age-Related Macular Degeneration: Results and Recommendations
Lee M. Jampol
Arch Ophthalmol. 2001;119(10):1533-1534.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Cost-effectiveness of Welcome to Medicare Visual Acuity Screening and a Possible Alternative Welcome to Medicare Eye Evaluation Among Persons Without Diagnosed Diabetes Mellitus
Rein et al.
Arch Ophthalmol 2012;0:archopthalmol.2011.1921v1-8.
ABSTRACT | FULL TEXT  

Risk Assessment Model for Development of Advanced Age-Related Macular Degeneration
Klein et al.
Arch Ophthalmol 2011;129:1543-1550.
ABSTRACT | FULL TEXT  

Central Areolar Choroidal Dystrophy (CACD) and Age-Related Macular Degeneration (AMD): Differentiating Characteristics in Multimodal Imaging
Smailhodzic et al.
IOVS 2011;52:8908-8918.
ABSTRACT | FULL TEXT  

Beyond AREDS: Is There a Place for Antioxidant Therapy in the Prevention/Treatment of Eye Disease?
Kowluru and Zhong
IOVS 2011;52:8665-8671.
ABSTRACT | FULL TEXT  

Lipid metabolites in the pathogenesis and treatment of neovascular eye disease
Stahl et al.
Br J Ophthalmol 2011;95:1496-1501.
ABSTRACT | FULL TEXT  

Upregulation of CCR3 by Age-Related Stresses Promotes Choroidal Endothelial Cell Migration via VEGF-Dependent and -Independent Signaling
Wang et al.
IOVS 2011;52:8271-8277.
ABSTRACT | FULL TEXT  

Effects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients with Age-Related Macular Degeneration
Weigert et al.
IOVS 2011;52:8174-8178.
ABSTRACT | FULL TEXT  

Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Klein et al.
JAMA 2011;306:1549-1556.
ABSTRACT | FULL TEXT  

Complement Deposition and Microglial Activation in the Outer Retina in Light-Induced Retinopathy: Inhibition by a 5-HT1A Agonist
Collier et al.
IOVS 2011;52:8108-8116.
ABSTRACT | FULL TEXT  

Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration
Yu et al.
Hum Mol Genet 2011;20:3699-3709.
ABSTRACT | FULL TEXT  

Evidence-based clinical guidelines for immigrants and refugees
Pottie et al.
CMAJ 2011;183:E824-E925.
FULL TEXT  

Vascular cell-adhesion molecule-1 plays a central role in the proangiogenic effects of oxidative stress
Dong et al.
Proc. Natl. Acad. Sci. USA 2011;108:14614-14619.
ABSTRACT | FULL TEXT  

The Effect of Photo-oxidative Stress and Inflammatory Cytokine on Complement Factor H Expression in Retinal Pigment Epithelial Cells
Lau et al.
IOVS 2011;52:6832-6841.
ABSTRACT | FULL TEXT  

Development and validation of a computer-aided diagnostic tool to screen for age-related macular degeneration by optical coherence tomography
Serrano-Aguilar et al.
Br J Ophthalmol 2011;0:bjophthalmol-2011-300660v-bjophthalmol-2011-300660.
ABSTRACT | FULL TEXT  

Peripheral corneal ring due to hypercarotenaemia in a case of nutritional supplement abuse
Chang et al.
Br J Ophthalmol 2011;0:bjophthalmol-2011-300746v-bjophthalmol-2011-300746.
FULL TEXT  

Age-related macular degeneration: the importance of family history as a risk factor
Shahid et al.
Br J Ophthalmol 2011;0:bjophthalmol-2011-300193v-bjophthalmol-2011-300193.
ABSTRACT | FULL TEXT  

Dietary {omega}-3 Fatty Acid and Fish Intake and Incident Age-Related Macular Degeneration in Women
Christen et al.
Arch Ophthalmol 2011;129:921-929.
ABSTRACT | FULL TEXT  

Serum Carotenoids and Risk of Age-Related Macular Degeneration in a Chinese Population Sample
Zhou et al.
IOVS 2011;52:4338-4344.
ABSTRACT | FULL TEXT  

Nutritional Manipulation of Primate Retinas, V: Effects of Lutein, Zeaxanthin, and n-3 Fatty Acids on Retinal Sensitivity to Blue-Light-Induced Damage
Barker et al.
IOVS 2011;52:3934-3942.
ABSTRACT | FULL TEXT  

Genetic Association with Response to Intravitreal Ranibizumab in Patients with Neovascular AMD
Kloeckener-Gruissem et al.
IOVS 2011;52:4694-4702.
ABSTRACT | FULL TEXT  

Estimated Cases of Legal Blindness and Visual Impairment Avoided Using Ranibizumab for Choroidal Neovascularization: Non-Hispanic White Population in the United States With Age-Related Macular Degeneration
Bressler et al.
Arch Ophthalmol 2011;129:709-717.
ABSTRACT | FULL TEXT  

Reducing the Genetic Risk of Age-Related Macular Degeneration With Dietary Antioxidants, Zinc, and {omega}-3 Fatty Acids: The Rotterdam Study
Ho et al.
Arch Ophthalmol 2011;129:758-766.
ABSTRACT | FULL TEXT  

Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration
Zhang et al.
Proc. Natl. Acad. Sci. USA 2011;108:6241-6245.
ABSTRACT | FULL TEXT  

Noise-Induced Hearing Loss: The Potential for Otoprotection
Le Prell
Hearing and Hearing Disorders: Research and Diagnostics 2011;15:25-33.
ABSTRACT | FULL TEXT  

Healthy Lifestyles Related to Subsequent Prevalence of Age-Related Macular Degeneration
Mares et al.
Arch Ophthalmol 2011;129:470-480.
ABSTRACT | FULL TEXT  

Cell-Deposited Matrix Improves Retinal Pigment Epithelium Survival on Aged Submacular Human Bruch's Membrane
Sugino et al.
IOVS 2011;52:1345-1358.
ABSTRACT | FULL TEXT  

Dark Matters in AMD Genetics: Epigenetics and Stochasticity
Hjelmeland
IOVS 2011;52:1622-1631.
FULL TEXT  

Choriocapillaris Vascular Dropout Related to Density of Drusen in Human Eyes with Early Age-Related Macular Degeneration
Mullins et al.
IOVS 2011;52:1606-1612.
ABSTRACT | FULL TEXT  

The Oral Iron Chelator Deferiprone Protects against Iron Overload-Induced Retinal Degeneration
Hadziahmetovic et al.
IOVS 2011;52:959-968.
ABSTRACT | FULL TEXT  

Drusen Analysis in a Human-Machine Synergistic Framework
Smith et al.
Arch Ophthalmol 2011;129:40-47.
ABSTRACT | FULL TEXT  

Prevalence of Age-Related Macular Degeneration in the US Population
Klein et al.
Arch Ophthalmol 2011;129:75-80.
ABSTRACT | FULL TEXT  

Performance of Drusen Detection by Spectral-Domain Optical Coherence Tomography
Schlanitz et al.
IOVS 2010;51:6715-6721.
ABSTRACT | FULL TEXT  

Influence of Saffron Supplementation on Retinal Flicker Sensitivity in Early Age-Related Macular Degeneration
Falsini et al.
IOVS 2010;51:6118-6124.
ABSTRACT | FULL TEXT  

Dynamic soft drusen remodelling in age-related macular degeneration
Smith et al.
Br J Ophthalmol 2010;94:1618-1623.
ABSTRACT | FULL TEXT  

Effect of isometric exercise on choroidal blood flow in patients with age-related macular degeneration
Metelitsina et al.
Br J Ophthalmol 2010;94:1629-1631.
ABSTRACT | FULL TEXT  

Increase of 8-Hydroxy-2'-Deoxyguanosine in Aqueous Humor of Patients with Exudative Age-Related Macular Degeneration
Lau et al.
IOVS 2010;51:5486-5490.
ABSTRACT | FULL TEXT  

17-{beta} Estradiol Protects ARPE-19 Cells from Oxidative Stress through Estrogen Receptor-{beta}
Giddabasappa et al.
IOVS 2010;51:5278-5287.
ABSTRACT | FULL TEXT  

Polymorphisms of the DNA Repair Genes XPD and XRCC1 and the Risk of Age-Related Macular Degeneration
Gorgun et al.
IOVS 2010;51:4732-4737.
ABSTRACT | FULL TEXT  

Choroidal Blood Flow and Progression of Age-Related Macular Degeneration in the Fellow Eye in Patients with Unilateral Choroidal Neovascularization
Boltz et al.
IOVS 2010;51:4220-4225.
ABSTRACT | FULL TEXT  

Exfoliation syndrome in the Reykjavik Eye Study: risk factors for baseline prevalence and 5-year incidence
Arnarsson et al.
Br J Ophthalmol 2010;94:831-835.
ABSTRACT | FULL TEXT  

Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent
Bao et al.
Am J Clin Nutr 2010;91:1634-1641.
ABSTRACT | FULL TEXT  

Healthy Diets and the Subsequent Prevalence of Nuclear Cataract in Women
Mares et al.
Arch Ophthalmol 2010;128:738-749.
ABSTRACT | FULL TEXT  

Quantitative Proteomics: Comparison of the Macular Bruch Membrane/Choroid Complex from Age-related Macular Degeneration and Normal Eyes
Yuan et al.
Mol. Cell. Proteomics 2010;9:1031-1046.
ABSTRACT | FULL TEXT  

Prevalence of Ocular Fundus Pathology in Patients with Chronic Kidney Disease
Grunwald et al.
CJASN 2010;5:867-873.
ABSTRACT | FULL TEXT  

Skin autofluorescence is elevated in neovascular age-related macular degeneration
Mulder et al.
Br J Ophthalmol 2010;94:622-625.
ABSTRACT | FULL TEXT  

Structural characterization of bisretinoid A2E photocleavage products and implications for age-related macular degeneration
Wu et al.
Proc. Natl. Acad. Sci. USA 2010;107:7275-7280.
ABSTRACT | FULL TEXT  

Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC)
Neale et al.
Proc. Natl. Acad. Sci. USA 2010;107:7395-7400.
ABSTRACT | FULL TEXT  

Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration
Curcio et al.
J. Lipid Res. 2010;51:451-467.
ABSTRACT | FULL TEXT  

Complement, Age-Related Macular Degeneration and a Vision of the Future
Gehrs et al.
Arch Ophthalmol 2010;128:349-358.
ABSTRACT | FULL TEXT  

Age related macular degeneration
Chakravarthy et al.
BMJ 2010;340:c981-c981.
FULL TEXT  

The Complexity of Animal Model Generation for Complex Diseases
Campochiaro
JAMA 2010;303:657-658.
FULL TEXT  

Development of Choroidal Neovascularization in Rats With Advanced Intense Cyclic Light-Induced Retinal Degeneration
Albert et al.
Arch Ophthalmol 2010;128:212-222.
ABSTRACT | FULL TEXT  

Effects of Antioxidants (AREDS Medication) on Ocular Blood Flow and Endothelial Function in an Endotoxin-Induced Model of Oxidative Stress in Humans
Pemp et al.
IOVS 2010;51:2-6.
ABSTRACT | FULL TEXT  

Association of Neovascular Age-Related Macular Degeneration with Specific Gene Expression Patterns in Peripheral White Blood Cells
Lederman et al.
IOVS 2010;51:53-58.
ABSTRACT | FULL TEXT  

{omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study
SanGiovanni et al.
Am J Clin Nutr 2009;90:1601-1607.
ABSTRACT | FULL TEXT  

Toll-like Receptor Polymorphisms and Age-Related Macular Degeneration: Replication in Three Case-Control Samples
Cho et al.
IOVS 2009;50:5614-5618.
ABSTRACT | FULL TEXT  

Summary Results and Recommendations From the Age-Related Eye Disease Study
Chew et al.
Arch Ophthalmol 2009;127:1678-1679.
FULL TEXT  

Legacy of the Age-Related Eye Disorder Study
Miller
Arch Ophthalmol 2009;127:1680-1685.
FULL TEXT  

Consumption of 2 and 4 egg yolks/d for 5 wk increases macular pigment concentrations in older adults with low macular pigment taking cholesterol-lowering statins
Vishwanathan et al.
Am J Clin Nutr 2009;90:1272-1279.
ABSTRACT | FULL TEXT  

Synthetic Triterpenoids Attenuate Cytotoxic Retinal Injury: Cross-talk between Nrf2 and PI3K/AKT Signaling through Inhibition of the Lipid Phosphatase PTEN
Pitha-Rowe et al.
IOVS 2009;50:5339-5347.
ABSTRACT | FULL TEXT  

Retinal drusen: harbingers of age, safe havens for trouble
Williams et al.
Age Ageing 2009;38:648-654.
ABSTRACT | FULL TEXT  

Association Between Dietary Fat Intake and Age-Related Macular Degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS): An Ancillary Study of the Women's Health Initiative
Parekh et al.
Arch Ophthalmol 2009;127:1483-1493.
ABSTRACT | FULL TEXT  

Molecular regulation of cigarette smoke induced-oxidative stress in human retinal pigment epithelial cells: implications for age-related macular degeneration
Bertram et al.
Am. J. Physiol. Cell Physiol. 2009;297:C1200-C1210.
ABSTRACT | FULL TEXT  

Relationship between RPE and Choriocapillaris in Age-Related Macular Degeneration
McLeod et al.
IOVS 2009;50:4982-4991.
ABSTRACT | FULL TEXT  

Enhanced HtrA2/Omi Expression in Oxidative Injury to Retinal Pigment Epithelial Cells and Murine Models of Neurodegeneration
Ding et al.
IOVS 2009;50:4957-4966.
ABSTRACT | FULL TEXT  

Evaluation of Potential Therapies for a Mouse Model of Human Age-Related Macular Degeneration Caused by Delayed all-trans-Retinal Clearance
Maeda et al.
IOVS 2009;50:4917-4925.
ABSTRACT | FULL TEXT  

Change in Area of Geographic Atrophy in the Age-Related Eye Disease Study: AREDS Report Number 26
The AREDS Research Group
Arch Ophthalmol 2009;127:1168-1174.
ABSTRACT | FULL TEXT  

Does eating particular diets alter the risk of age-related macular degeneration in users of the Age-Related Eye Disease Study supplements?
Chiu et al.
Br J Ophthalmol 2009;93:1241-1246.
ABSTRACT | FULL TEXT  

RE: "RED MEAT AND CHICKEN CONSUMPTION AND ITS ASSOCIATION WITH AGE-RELATED MACULAR DEGENERATION"
Flood et al.
Am J Epidemiol 2009;170:531-532.
FULL TEXT  

Plasma Protein Pentosidine and Carboxymethyllysine, Biomarkers for Age-related Macular Degeneration
Ni et al.
Mol. Cell. Proteomics 2009;8:1921-1933.
ABSTRACT | FULL TEXT  

Multivitamin Supplements, Ageing, and Loss of Vision: Seeing Through the Shadows
Phillips and Higginbotham
Arch Intern Med 2009;169:1180-1182.
FULL TEXT  

Screening Older Adults for Impaired Visual Acuity: A Review of the Evidence for the U.S. Preventive Services Task Force
Chou et al.
ANN INTERN MED 2009;151:44-58.
ABSTRACT | FULL TEXT  

Complement Component 3 (C3) Haplotypes and Risk of Advanced Age-Related Macular Degeneration
Park et al.
IOVS 2009;50:3386-3393.
ABSTRACT | FULL TEXT  

Impact of the Discovery of Human Zinc Deficiency on Health
Prasad
J. Am. Coll. Nutr. 2009;28:257-265.
ABSTRACT | FULL TEXT  

Assessing Susceptibility to Age-related Macular Degeneration with Proteomic and Genomic Biomarkers
Gu et al.
Mol. Cell. Proteomics 2009;8:1338-1349.
ABSTRACT | FULL TEXT  

Forecasting Age-Related Macular Degeneration Through 2050
Klein and Klein
JAMA 2009;301:2152-2153.
FULL TEXT  

Prediction Model for Prevalence and Incidence of Advanced Age-Related Macular Degeneration Based on Genetic, Demographic, and Environmental Variables
Seddon et al.
IOVS 2009;50:2044-2053.
ABSTRACT | FULL TEXT  

The Flavonoid, Eriodictyol, Induces Long-term Protection in ARPE-19 Cells through Its Effects on Nrf2 Activation and Phase 2 Gene Expression
Johnson et al.
IOVS 2009;50:2398-2406.
ABSTRACT | FULL TEXT  

A Hybrid Cohort Individual Sampling Natural History Model of Age-Related Macular Degeneration: Assessing the Cost-Effectiveness of Screening Using Probabilistic Calibration
Karnon et al.
Med Decis Making 2009;29:304-316.
ABSTRACT  

Dietary Fatty Acids and the 10-Year Incidence of Age-Related Macular Degeneration: The Blue Mountains Eye Study
Tan et al.
Arch Ophthalmol 2009;127:656-665.
ABSTRACT | FULL TEXT  

Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss
Francis et al.
J. Med. Genet. 2009;46:300-307.
ABSTRACT | FULL TEXT  

BMP4 Mediates Oxidative Stress-induced Retinal Pigment Epithelial Cell Senescence and Is Overexpressed in Age-related Macular Degeneration
Zhu et al.
J. Biol. Chem. 2009;284:9529-9539.
ABSTRACT | FULL TEXT  

Micronutrients and Older Adults
Marian and Sacks
Nutr Clin Pract 2009;24:179-195.
ABSTRACT | FULL TEXT  

Coenzyme Q10 in the Human Retina
Qu et al.
IOVS 2009;50:1814-1818.
ABSTRACT | FULL TEXT  

Forecasting Age-Related Macular Degeneration Through the Year 2050: The Potential Impact of New Treatments
Rein et al.
Arch Ophthalmol 2009;127:533-540.
ABSTRACT | FULL TEXT  

Complement Activation by Bisretinoid Constituents of RPE Lipofuscin
Zhou et al.
IOVS 2009;50:1392-1399.
ABSTRACT | FULL TEXT